title: Should ethnicity serve as the basis for clinical trial design? Diversity and inclusiveness should remain the guiding principles for clinical trials.
authors.affiliation: Department of Preventive Medicine and Epidemiology, Loyola Stritch School of Medicine, Maywood, IL 60153, USA. rcooper@lumc.edu
authors.forename: Richard S
authors.initials: RS
authors.lastname: Cooper
authors.forename: Bruce M
authors.initials: BM
authors.lastname: Psaty
mesh_terms: D001741:Black or African American; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002985:Clinical Protocols; D002986:Clinical Trials as Topic / Q000379:methods*; D005006:Ethnicity; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D006977:Hypertension, Renal; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D007674:Kidney Diseases / Q000150:complications / Q000188:drug therapy*; D009203:Myocardial Infarction / Q000517:prevention & control*; D044469:Racial Groups
chemical_list: D000959:Antihypertensive Agents; D000960:Hypolipidemic Agents